97 related articles for article (PubMed ID: 1146929)
1. Effects of 0.5 mg. of lynestrenol daily on hypothalamic-pituitary-ovarian function.
Friedrich E; Keller E; Jaeger-Whitegiver ER; Joel EW; Schindler AE
Am J Obstet Gynecol; 1975 Jul; 122(5):642-9. PubMed ID: 1146929
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
4. [The effect of low dose gestagens on the hypothalamic-pituitary-ovarian axis].
Friedrich E
Fortschr Med; 1977 Aug; 95(29):1827-32. PubMed ID: 885464
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
6. [The low dosis gestagen therapy (author's transl)].
Mall-Haefeli M; Ludwig KS; Spornitz UM; Uettwiller A
Geburtshilfe Frauenheilkd; 1976 Aug; 36(8):645-60. PubMed ID: 976705
[TBL] [Abstract][Full Text] [Related]
7. FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.
van Heusden AM; Coelingh Bennink HJ; Fauser BC
Clin Endocrinol (Oxf); 2002 Apr; 56(4):509-17. PubMed ID: 11966744
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
9. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
10. Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin.
Tafurt CA; Sobrevilla LA; de Estrada R
Fertil Steril; 1980 Mar; 33(3):261-6. PubMed ID: 6767626
[TBL] [Abstract][Full Text] [Related]
11. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
13. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
Hemrika DJ; Slaats EH; Schoemaker J
Am J Obstet Gynecol; 1994 Feb; 170(2):462-8. PubMed ID: 8116698
[TBL] [Abstract][Full Text] [Related]
14. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
15. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
16. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
17. [The effect of different types of oral contraceptives upon ovarian function (author's transl)].
Aktories K; Krög W; Dericks-Tan JS; Jürgensen O; Taubert HD
Geburtshilfe Frauenheilkd; 1976 Apr; 36(4):318-26. PubMed ID: 1269893
[TBL] [Abstract][Full Text] [Related]
18. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
19. [The hormonal basis of discontinuous progestational contraception (author's transl)].
Kuttenn F; Moufarège A; Mauvais-Jarvis P
Nouv Presse Med; 1978 Oct; 7(35):3109-13. PubMed ID: 724470
[TBL] [Abstract][Full Text] [Related]
20. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
Korkhov VV; Nikanorova SA
Farmakol Toksikol; 1987; 50(1):97-100. PubMed ID: 3556564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]